Sensus Healthcare Receives FDA 510k Clearance for Next Generation Image Guided Superficial Radiotherapy SRT-100 Vision(TM)
October 19, 2015 09:02 ET
|
SENSUS Healthcare
SAN ANTONIO, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Sensus Healthcare, the market leader in superficial radiation therapy treatment of skin cancer and keloids, announces FDA clearance for the next...
North Shore-LIJ Cancer Institute Affiliates with Suffolk Radiation Medicine Practices
September 23, 2013 16:00 ET
|
North Shore Long Island Jewish Health System
SMITHTOWN, N.Y., Sept. 23, 2013 (GLOBE NEWSWIRE) -- The North Shore-LIJ Health System today announced the signing of a joint venture agreement with North Shore Radiation Therapy, CyberKnife of Long...
HealthEast Announces Woodbury Expansion Plans
September 10, 2013 19:30 ET
|
HealthEast Care System
WOODBURY, MN--(Marketwired - Sep 10, 2013) - As a part of a continuing plan to transform based on ACA requirements and in keeping with a long-standing objective of compassionate care in the...
Medicare Announces 2013 Physician Fee Schedule Including Seven Percent Cut to Radiation Oncology and Nine Percent Cut to Radiation Therapy Centers
November 02, 2012 15:39 ET
|
American Society for Radiation Oncology
FAIRFAX, Va., Nov. 2, 2012 (GLOBE NEWSWIRE) -- The Centers for Medicare and Medicaid Services (CMS) issued the final rule on November 1, 2012, that will revise several reimbursement payment policies...
Stereotactic Radiosurgery Shows Promise as a Therapeutic Option for Patients With Primary Renal Cancer
October 31, 2012 07:05 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 31, 2012 (GLOBE NEWSWIRE) -- The first trial of safety and toxicity shows promise for stereotactic radiosurgery as a therapeutic option for patients with localized primary renal cancer...
Intermediate-Risk Patients With Organ-Confined Prostate Cancer Have High Cancer-Free Survival Rate After Stereotactic Body Radiation Therapy
October 30, 2012 16:00 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiotherapy (SBRT) yields excellent cancer-free survival rates for intermediate-risk, organ-confined prostate cancer patients and results...
High Doses of Stereotactic Body Radiotherapy for Patients With Organ-Confined Prostate Cancer Shows High Relapse-Free Survival
October 30, 2012 15:53 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of...
Annual Prostate Cancer Screening Improves Quality-Adjusted Life Expectancy for High-Risk Patients Compared to Unscreened Patients
October 30, 2012 13:42 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Annual prostate-specific antigen (PSA) screening yields a greater quality-adjusted life expectancy (QALE) among patients who have a high-risk of developing...
Accelerated Partial Breast Irradiation Using 3-D Conformal External Beam Radiation Therapy is Associated With a Negative Cosmetic Outcome Compared to Whole Breast Irradiation in Some Breast Cancer Patients
October 29, 2012 14:38 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Accelerated partial breast irradiation using 3-D conformal external beam radiation therapy is associated with a negative cosmetic outcome compared to whole...
Stereotactic Body Radiation Therapy Shows Advances for Inoperable, Non-Small Cell Lung Cancer Patients
October 29, 2012 11:16 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiation therapy (SBRT) yielded higher overall survival rates and low toxicity for patients with inoperable, non-small cell lung cancer...